Kenvue has appointed Andrew Stanleick to the role of president, skin health & beauty for North America and Europe, Middle East and Africa, leading the strategic direction of its iconic of brands, including Neutrogena, Aveeno and OGX, in the regions.
“We are very pleased to have Andrew join Kenvue in this critical role,” said Charmaine England, chief growth officer, Kenvue.
“With over two decades of experience in leading the profitable growth and omni-channel transformation of global multi-brand portfolios in skin health, beauty and fashion, Andrew brings a proven track-record of success and deep industry knowledge to strengthen the growth trajectory of our Skin Health & Beauty segment in key markets.”
“I am thrilled to join the Kenvue team at such an exciting time for the Company,” said Andrew Stanleick. “As a global leader in consumer health, Kenvue’s iconic skin health and beauty brands have been trusted by consumers and recommended by healthcare professionals for generations. I look forward to helping these brands reach more consumers in new ways in 2025 and beyond.”
Kenvue appoints new skin health & beauty president for NA, EMEA
